Back to Results
First PageMeta Content
Medicine / Clinical medicine / Health / Tyrosine kinase inhibitors / Clinical pharmacology / Breakthrough therapy / Nintedanib / Piperazines / Thrombocytopenia / Kasumigaseki / Package insert / Adverse effect


Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl
Add to Reading List

Document Date: 2016-08-04 23:26:42


Open Document

File Size: 28,95 KB

Share Result on Facebook
UPDATE